These data support a role for host MSLN expression in the regulation of peritoneal tissue ultrastructure thereby impacting ovarian tumor metastatic success and provide support for further investigation of host MSLN as a target in ovarian cancer. This evidence concerns the gene MSLN and ovarian neoplasm.